Human CD102 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human CD102 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD102 |
| Clone | [CBRIC2/2] |
| Host Species | Mouse |
| Reactive Species | n/a |
| Isotype | IgG2a |
| Format | fluorescein (FITC) conjugate |
| Size | 0.1 mg |
| Concentration | IgG concentration 0.1 mg/ml |
| Applications | Flow cytometry (FC/FACS) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Mouse anti Human CD102 antibody, clone CBRIC2/2 recognizes human CD102, also known as intercellular adhesion molecule-2 (ICAM-2). CD102 is a glycosylated cell surface protein that is broadly expressed on most leucocytes and is strongly expressed by endothelial cells. CD102 interacts with the CD11a/CD18 (LFA-1). Reports suggest that the CD102 may play a role in lymphocyte re-circulation and T-cell activation. Mouse anti Human CD102 antibody, clone CBRIC2/2 is reported to inhibit interactions between CD102 and LFA-1 (De Fougerolles et al. 1991). |
| Immunogen | Immunogen: Transfected COS cells expressing ICAM-2 cDNA Fusion Partners: Cells from immunised BALB/c mice were fused with cells of the Murine P3X63Ag.653 myeloma cell line. Buffer Solution: Phosphate buffered saline Target Species: Human |
| Other Names | [intercellular adhesion molecule 2; Intercellular adhesion molecule 2; intercellular adhesion molecule 2; ICAM-2; intercellular adhesion molecule 2; CD_antigen: CD102], [ICAM2; ICAM2; CD102; ICAM-2] |
| Gene, Accession # | [CD102], Gene ID: 3384, NCBI: NP_000864.2, UniProt: P13598 |
| Catalog # | MBS210922 |
| Price | $370 |
| Order / More Info | Human CD102 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies